Same Indication

Ipilimumab vs Spironolactone

Ipilimumab vs Spironolactone: Overview

This comparison examines the pharmacological differences between Ipilimumab and Spironolactone.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Spironolactone: Mineralocorticoid receptor antagonist.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Spironolactone β€” 1.4 hours.

Chemical Properties

Molecular Formula: Spironolactone β€” C24H32O4S.

Molecular Weight: Spironolactone β€” 416.5740 g/mol.

Type: Ipilimumab β€” Antibody; Spironolactone β€” Small molecule.